Can-Fite BioPharma (CANF) Stock Trends and Sentiment $2.34 -0.10 (-4.10%) (As of 02:58 PM ET) Add Compare Share Share TrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends Media Mentions Over Time2 Last Week 1 Current Week -50.0%View Trending Media Stocks MarketBeat New Followers Over Time1 Last Week 1 Current Week View Trending Stocks on MarketBeat MarketBeat Searches Over Time0 Last Week 2 Current Week +200.0% Page Views Over Time350 Last Week 300 Current Week -14.3% Recieve Can-Fite BioPharma News and Ratings via Email Sign-up to receive the latest news and ratings for CANF and its competitors with MarketBeat's FREE daily newsletter. Email Address CANF Social Media Mentions Related Companies and Tools Related Companies: Acurx Pharmaceuticals Stock Sentiment Tempest Therapeutics Stock Sentiment Surrozen Stock Sentiment Lumos Pharma Stock Sentiment Quince Therapeutics Stock Sentiment Achilles Therapeutics Stock Sentiment OKYO Pharma Stock Sentiment Pluri Stock Sentiment Daré Bioscience Stock Sentiment Cue Biopharma Stock Sentiment Trends Tools: Trending StocksTrending Media MentionsHigh Media Sentiment StocksTrending WallStreetBets StocksLive News Feed This page (NYSE:CANF) was last updated on 9/13/2024 by MarketBeat.com Staff From Our PartnersYou won’t believe what this ex-Wall Street insider discovered about the electionOne ex-Wall Street insider recently combed through 64 years of election data… And he just uncovered somethi...Banyan Hill Publishing | Sponsored Turn Smartphones Into “Earnphones”?High-Growth Smartphone Startup 45 Million Users. $60M+ in Revenue. 32,481% Growth Rate. $1T+ market opportu...Mode Mobile | SponsoredBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredInvest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges ...Deal Maker | SponsoredPlace this $0.99 trade BEFORE the electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThe $15 "Insider Secret" That Could Save Your RetirementWhat if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's righ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can-Fite BioPharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can-Fite BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
